AMANDA KONIECZNY: Open Payments
NPI 1225600505 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 82 payments from 21 companies in 2025. Trend: 2023 $470 · 2024 $464 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $409 |
| Novo Nordisk Inc | 8 | $191 |
| Lilly USA, LLC | 9 | $182 |
| AstraZeneca Pharmaceuticals LP | 9 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $130 |
| Abbott Laboratories | 5 | $101 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| SANOFI-AVENTIS U.S. LLC | 2 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $55 |
| Astellas Pharma US Inc | 2 | $51 |
Products named: UBRELVY, JARDIANCE, AIRSUPRA, Wegovy, QULIPTA, FREESTYLE LIBRE 3, TZIELD, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
